Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miso Kim

Showing results (121-130 of 184) with videos related to

Pageof 19
Sort By:
BMB Reports|May 11, 2021
Common and differential effects of docosahexaenoic acid and eicosapentaenoic acid on helper T-cell responses and associated pathwaysJaeho Lee, Yu Ri Choi, Miso Kim, et al.
Yonsei Medical Journal|February 14, 2018
Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung CancerJaemin Jo, Se Hyun Kim, Yu Jung Kim, et al.
Breast Cancer Research and Treatment|September 7, 2022
Prognostic role of tumor subtype and germline BRCA mutation in advanced breast cancer patients treated with palbociclib plus endocrine therapySong Yi Park, Koung Jin Suh, Dae-Won Lee, et al.
The Oncologist|July 4, 2019
Prognostic Impact of Pregnancy in Korean Patients with Breast CancerMihong Choi, Jiyeon Han, Bo Ram Yang, et al.
Cancer Research and Treatment|December 15, 2017
The Impact of Skin Problems on the Quality of Life in Patients Treated with Anticancer Agents: A Cross-Sectional StudyJaewon Lee, Jin Lim, Jong Seo Park, et al.
Clinical Breast Cancer|September 17, 2019
Development of a Nomogram to Predict the Recurrence Score of 21-Gene Prediction Assay in Hormone Receptor-Positive Early Breast CancerShin Hye Yoo, Tae-Yong Kim, Miso Kim, et al.
Anticancer Research|April 12, 2012
The prognostic significance of HER2 positivity for advanced gastric cancer patients undergoing first-line modified FOLFOX-6 regimenJin Won Kim, Seock-Ah Im, Miso Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|September 9, 2019
A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancerYu-Jung Kim, Bhumsuk Keam, Chan-Young Ock, et al.
The Korean Journal of Internal Medicine|November 21, 2017
Clinical significance of rituximab infusion-related reaction in diffuse large B-cell lymphoma patients receiving R-CHOPKyoung Min Cho, Bhumsuk Keam, Hyerim Ha, et al.
Cancer Research and Treatment|July 5, 2017
Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal TypeHyun Jee Kim, Chan-Young Ock, Tae Min Kim, et al.
Pageof 19

Showing results (121-130 of 184) with videos related to

Sort By:
Pageof 19
BMB Reports|May 11, 2021
Common and differential effects of docosahexaenoic acid and eicosapentaenoic acid on helper T-cell responses and associated pathwaysJaeho Lee, Yu Ri Choi, Miso Kim, et al.
Yonsei Medical Journal|February 14, 2018
Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung CancerJaemin Jo, Se Hyun Kim, Yu Jung Kim, et al.
Breast Cancer Research and Treatment|September 7, 2022
Prognostic role of tumor subtype and germline BRCA mutation in advanced breast cancer patients treated with palbociclib plus endocrine therapySong Yi Park, Koung Jin Suh, Dae-Won Lee, et al.
The Oncologist|July 4, 2019
Prognostic Impact of Pregnancy in Korean Patients with Breast CancerMihong Choi, Jiyeon Han, Bo Ram Yang, et al.
Cancer Research and Treatment|December 15, 2017
The Impact of Skin Problems on the Quality of Life in Patients Treated with Anticancer Agents: A Cross-Sectional StudyJaewon Lee, Jin Lim, Jong Seo Park, et al.
Clinical Breast Cancer|September 17, 2019
Development of a Nomogram to Predict the Recurrence Score of 21-Gene Prediction Assay in Hormone Receptor-Positive Early Breast CancerShin Hye Yoo, Tae-Yong Kim, Miso Kim, et al.
Anticancer Research|April 12, 2012
The prognostic significance of HER2 positivity for advanced gastric cancer patients undergoing first-line modified FOLFOX-6 regimenJin Won Kim, Seock-Ah Im, Miso Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|September 9, 2019
A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancerYu-Jung Kim, Bhumsuk Keam, Chan-Young Ock, et al.
The Korean Journal of Internal Medicine|November 21, 2017
Clinical significance of rituximab infusion-related reaction in diffuse large B-cell lymphoma patients receiving R-CHOPKyoung Min Cho, Bhumsuk Keam, Hyerim Ha, et al.
Cancer Research and Treatment|July 5, 2017
Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal TypeHyun Jee Kim, Chan-Young Ock, Tae Min Kim, et al.
Pageof 19